Drug interactions
Argatroban + Conjugated estrogens vaginal
Severity: Minor
Argatroban and Conjugated estrogens vaginal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Estrogens can promote a prothrombotic state, which in theory opposes anticoagulation. With low-dose vaginal use, systemic exposure is small and the clinical effect on argatroban is minimal.
What this interaction means in plain words
Argatroban and Conjugated estrogens vaginal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Estrogen-induced increases in clotting factors oppose anticoagulant effect, although systemic absorption by the vaginal route is low.
What to do
No routine change is needed. Monitor aPTT and clinical thrombosis in patients receiving argatroban for heparin-induced thrombocytopenia.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Argatroban and Conjugated estrogens vaginal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Argatroban
- Argatroban + Defibrotide Contraindicated
- Argatroban + Ketorolac Contraindicated
- Argatroban + Mifepristone Contraindicated
- Abciximab + Argatroban Major
- Acalabrutinib + Argatroban Major
- Acetylsalicylic acid + Argatroban Major
Frequently asked questions
Can I take Argatroban with Conjugated estrogens vaginal?
MediHelp rates the interaction as minor. Argatroban and Conjugated estrogens vaginal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Estrogens can promote a prothrombotic state, which in theory opposes anticoagulation. With low-dose vaginal use, systemic exposure is small and the clinical effect on argatroban is minimal.
How serious is the interaction between Argatroban and Conjugated estrogens vaginal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Monitor aPTT and clinical thrombosis in patients receiving argatroban for heparin-induced thrombocytopenia.
What other medicines interact with Argatroban?
MediHelp also lists interactions of Argatroban with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Argatroban page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
